ENDRA Life Sciences
Jeremy Gill is a highly experienced professional in the technology and healthcare sectors, currently serving as a Software Architect at ENDRA Life Sciences since April 2019. As the CEO of Parallax Innovations since April 2011, Jeremy has demonstrated entrepreneurial leadership. Prior experience includes roles as Systems Engineering Manager at Gamma Medica-Ideas and Software Manager at General Electric Healthcare, where Jeremy contributed to significant advancements in software and systems. Jeremy started in the field as a Software Programmer at Enhanced Vision Systems Corp. An accomplished academic, Jeremy holds a Ph.D. in Physics from Western University and two Master's degrees in Physics and Computer Science from McMaster University and The University of Western Ontario, respectively.
This person is not in any offices
ENDRA Life Sciences
2 followers
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), a ground-breaking technology being developed to visualize tissue like CT or MRI, but at 1/50th of the cost, at the point of patient care. TAEUS is initially focused on the measurement of fat in the liver, as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.